bigpharma   683

« earlier    

Trump MUST remove giveaways from 2.0 before Congress puts the deal up for a vote. Add your name a…
NAFTA  BigPharma  from twitter
4 days ago by rgl7194
Opinion | Be Afraid of Economic ‘Bigness.’ Be Very Afraid. - The New York Times
"There are many differences between the situation in 1930s and our predicament today. But given what we know, it is hard to avoid the conclusion that we are conducting a dangerous economic and political experiment: We have chosen to weaken the laws — the antitrust laws — that are meant to resist the concentration of economic power in the United States and around the world.

From a political perspective, we have recklessly chosen to tolerate global monopolies and oligopolies in finance, media, airlines, telecommunications and elsewhere, to say nothing of the growing size and power of the major technology platforms. In doing so, we have cast aside the safeguards that were supposed to protect democracy against a dangerous marriage of private and public power.

Unfortunately, there are abundant signs that we are suffering the consequences, both in the United States and elsewhere. There is a reason that extremist, populist leaders like Jair Bolsonaro of Brazil, Xi Jinping of China and Viktor Orban of Hungary have taken center stage, all following some version of the same script. And here in the United States, we have witnessed the anger borne of ordinary citizens who have lost almost any influence over economic policy — and by extension, their lives. The middle class has no political influence over their stagnant wages, tax policy, the price of essential goods or health care. This powerlessness is brewing a powerful feeling of outrage."

"In recent years, we have allowed unhealthy consolidations of hospitals and the pharmaceutical industry; accepted an extraordinarily concentrated banking industry, despite its repeated misfeasance; failed to prevent firms like Facebook from buying up their most effective competitors; allowed AT&T to reconsolidate after a well-deserved breakup in the 1980s; and the list goes on. Over the last two decades, more than 75 percent of United States industries have experienced an increase in concentration, while United States public markets have lost almost 50 percent of their publicly traded firms.

There is a direct link between concentration and the distortion of democratic process. As any undergraduate political science major could tell you, the more concentrated an industry — the fewer members it has — the easier it is to cooperate to achieve its political goals. A group like the middle class is hopelessly disorganized and has limited influence in Congress. But concentrated industries, like the pharmaceutical industry, find it easy to organize to take from the public for their own benefit. Consider the law preventing Medicare from negotiating for lower drug prices: That particular lobbying project cost the industry more than $100 million — but it returns some $15 billion a year in higher payments for its products.

We need to figure out how the classic antidote to bigness — the antitrust and other antimonopoly laws — might be recovered and updated to address the specific challenges of our time. For a start, Congress should pass a new Anti-Merger Act reasserting that it meant what it said in 1950, and create new levels of scrutiny for mega-mergers like the proposed union of T-Mobile and Sprint.

But we also need judges who better understand the political as well as economic goals of antitrust. We need prosecutors willing to bring big cases with the courage of trustbusters like Theodore Roosevelt, who brought to heel the empires of J.P. Morgan and John D. Rockefeller, and with the economic sophistication of the men and women who challenged AT&T and Microsoft in the 1980s and 1990s. Europe needs to do its part as well, blocking more mergers, especially those like Bayer’s recent acquisition of Monsanto that threaten to put entire global industries in just a few hands.

The United States seems to constantly forget its own traditions, to forget what this country at its best stands for. We forget that America pioneered a kind of law — antitrust — that in the words of Roosevelt would “teach the masters of the biggest corporations in the land that they were not, and would not be permitted to regard themselves as, above the law.” We have forgotten that antitrust law had more than an economic goal, that it was meant fundamentally as a kind of constitutional safeguard, a check against the political dangers of unaccountable private power.

As the lawyer and consumer advocate Robert Pitofsky warned in 1979, we must not forget the economic origins of totalitarianism, that “massively concentrated economic power, or state intervention induced by that level of concentration, is incompatible with liberal, constitutional democracy.”"
timwu  economics  monopolies  history  bigness  scale  size  2018  telecommunications  healthcare  medicine  governance  democracy  fascism  government  influence  power  bigpharma  law  legal  robertpitofsky  consolidation  mergers  lobbying  middleclass  class  inequality 
november 2018 by robertogreco

« earlier    

related tags

2018  3dprinting  aaa  abpi  addiction  adherence  ageing  agression  alphabet  america  antibiotic  antibiotics  antidepressive  antitrust  approval  austerity  axa  badscience  bankster  behaviour  big  bigdata  bigness  bigtobacco  bioethics  bioinformatics  biometrics  biotech  blockbuster  boehringer  bone  bribery  bubble  business  businessmodel  cancer  canpoli  capitalism  care  cartel  cbts_stream  cdc  china  class  clinicalai  clinicaliai  clinicaltrial  clinicaltrials  collusion  competition  complex  computers  consolidation  consumerbehaviour  cooperation  corporate  corporateoverlords  corruption  costco  crime  cro  crony  data  dataanalytics  database  datasharing  deaths  delight  deloitte  demand  democracy  demographic  diabetes  dictator  digital  digitalhealth  digitaltherapeutics  digitaltwin  disease  doctors  drug  drugdelivery  drugdevelopment  drugdiscovery  drugs  dusruption  economics  ehr  eu  excess  exploitation  eyetech  fascism  fda  food–industrial  friction  genericdrugs  genomics  google  governance  government  greatawakening  hai  health  healthcare  history  hsk  hsklikes  industry  inequality  infection  influence  insurtech  iot  ip  jurisdiction  law  legal  listentothis  lobbying  longevity  machinelearning  maga  magic  marketing  maximisation  mcr-1  medical  medication  medicine  meds  mergers  mhealth  middleclass  mobile  monopolies  monopoly  monsanto  mrsa  ms  msd  myelin  nafta  nederland  neoliberalism  netneutrality  nhs  novonordisk  oligopol  oligopoly  oncology  online  ontpoli  opendata  opensource  opiate  osteopenia  osteoporosis  overmedication  oxy  oxycontin  paracetamol  parkinsons  patents  patient  payments  pfizer  pharma  pharmaceutical  physician  population  post-antibiotic  potus  power  prevention  pricing  privacy  privatisation  profit  programming  public  qanon  ra  rationing  reference  regenold  regulation  resist  review  robertpitofsky  rwd  safety  scale  sharing  shortage  sick  size  social  staff  startup  startups  stp  superbug  supplychain  telecommunications  thermometer  ticktock  tidepool  timwu  totwitter  trade  transformation  trends  trust  uk  us  usa  uspoli  uspolitics  vertex  wallstreet  wearables 

Copy this bookmark: